Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuchen Han

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Journal for Immunotherapy of Cancer|December 1, 2023
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitinationZhijia Sun, Haixing Mai, Chunyuan Xue, et al.
Journal of Hematology & Oncology|March 16, 2024
Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkersFahan Ma, Yan Li, Chan Xiang, et al.
Scientific Reports|December 20, 2019
Diaphragmatic dysfunction associates with dyspnoea, fatigue, and hiccup in haemodialysis patients: a cross-sectional studyBin Wang, Qing Yin, Ying-Yan Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2021
Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLCTianqing Chu, Runbo Zhong, Hua Zhong, et al.
The British Journal of Surgery|February 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trialYang Yang, Zhichao Liu, Ian Wong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 31, 2022
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinomaChan Xiang, Chunyu Ji, Yiran Cai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 6, 2024
Corrigendum to "Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma" [Modern Pathology. 2022;35(9):1181-1192]Chan Xiang, Chunyu Ji, Yiran Cai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 2026
NTRK Fusion Landscape in 195 Positive Cases of 17 Tumors: A Chinese Multicenter Retrospective Study with Optimized Pan-TRK IHC ScreeningShafei Wu, Jian Wang, Wentao Yang, et al.
Frontiers in Oncology|November 7, 2022
3D deep learning versus the current methods for predicting tumor invasiveness of lung adenocarcinoma based on high-resolution computed tomography imagesYilv Lv, Ying Wei, Kuan Xu, et al.
Hepatology (Baltimore, Md.)|July 29, 2021
LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCCLuyuan Ma, An Xu, Lei Kang, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Journal for Immunotherapy of Cancer|December 1, 2023
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitinationZhijia Sun, Haixing Mai, Chunyuan Xue, et al.
Journal of Hematology & Oncology|March 16, 2024
Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkersFahan Ma, Yan Li, Chan Xiang, et al.
Scientific Reports|December 20, 2019
Diaphragmatic dysfunction associates with dyspnoea, fatigue, and hiccup in haemodialysis patients: a cross-sectional studyBin Wang, Qing Yin, Ying-Yan Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2021
Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLCTianqing Chu, Runbo Zhong, Hua Zhong, et al.
The British Journal of Surgery|February 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trialYang Yang, Zhichao Liu, Ian Wong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 31, 2022
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinomaChan Xiang, Chunyu Ji, Yiran Cai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 6, 2024
Corrigendum to "Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma" [Modern Pathology. 2022;35(9):1181-1192]Chan Xiang, Chunyu Ji, Yiran Cai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 2026
NTRK Fusion Landscape in 195 Positive Cases of 17 Tumors: A Chinese Multicenter Retrospective Study with Optimized Pan-TRK IHC ScreeningShafei Wu, Jian Wang, Wentao Yang, et al.
Frontiers in Oncology|November 7, 2022
3D deep learning versus the current methods for predicting tumor invasiveness of lung adenocarcinoma based on high-resolution computed tomography imagesYilv Lv, Ying Wei, Kuan Xu, et al.
Hepatology (Baltimore, Md.)|July 29, 2021
LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCCLuyuan Ma, An Xu, Lei Kang, et al.
Pageof 17